Centene Boosts Behavioral Health Offerings With Magellan Buy

Following the recent acquisition of PANTHERx Rare, LLC and the first- quarter 2020 addition of WellCare Health Plans, Inc., Centene Corp. kicked off the new year with an agreement to purchase Magellan Health, Inc. for $2.2 billion. Magellan also just completed the previously disclosed sale of its managed care division to Molina Healthcare, Inc. The newer transaction will allow Centene to expand its behavioral health platform, increase its specialty health and pharmacy capabilities and enhance its ability to address members’ whole health.

During a Jan. 4 conference call to discuss the planned transaction, Centene Chairman, President and CEO Michael Neidorff said the combination is in line with the company’s diversification strategy and boosts Centene’s capacity to “provide comprehensive care to the most complex and vulnerable populations,” especially as it relates to behavioral health care.

© 2021 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_274078056.jpg
November 18

Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg
November 18

Given COVID Surge, Humana Deviates From Peers With Lower Guidance

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/WordPress-Featured-Image-radar-on-medicare-advantage-MedPAC-Reforms-to-Part-D-LIS-Could-Produce-Savings.jpg
November 18

Clover Health Struggles to Contain Medical Costs for MA Members

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today